Elevance Health Elevates 2026 Profit Forecast Following Greater Medical Costs Clarity

Elevance Health has increased its full-year 2026 outlook despite reporting a decline in first-quarter profit compared to the same period last year.

The firm is the second-largest health insurer in the U.S. behind UnitedHealthcare and is widely recognized for operating Blue Cross Blue Shield plans under the Anthem brand across 14 states. Beyond its commercial footprint, the company administers Medicaid programs through state contracts and offers individual market coverage under the Affordable Care Act. It also continues to expand its healthcare services arm, Carelon.

As is the case with most of the health insurers the company competes against, Elevance has been fighting increasing medical expenses from the customer side in its health plans, expectantly leading to a decline in net income.

The insurer posted net income of $1.8 billion for Q1 2026, representing an over 19% drop from the $2.2 billion recorded in Q1 2025. Even so, the results came in ahead of analyst expectations, according to Zacks Investment Research.

Quarterly revenue reached just over $50 billion, up 2.6% from $48.9 billion a year earlier, also surpassing Wall Street forecasts.

The company reported a medical loss ratio of 86.8% for the quarter, a slight increase year over year, reflecting elevated cost trends within its Medicaid business. However, stronger performance in Medicare helped offset some of those pressures.

Insurers typically aim to keep their benefit expense ratio – often referred to as the medical loss ratio – in the low- to mid-80% range. However, achieving that target has proven difficult over the past year, largely due to increased healthcare utilization. Many Americans, particularly older adults, delayed care during the COVID-19 pandemic and are now seeking treatment, driving up demand. As a result, insurers have continued to report elevated cost trends into this year.

Following these results, Elevance Health raised its earnings guidance and now expects to generate at least $26.75 in earnings per share for 2026, up from its previous projection of $25.50.

CEO Gail Boudreaux said the company’s first-quarter performance went better than expectations, driven by underlying business acumen and improving claims trends. She added that increased visibility into the remainder of the year supported the decision to lift full-year EPS guidance and reflects efforts to deliver more consistent performance over time.

Within its health benefits division, revenue totaled $42.5 billion in Q1, aided by higher premium yields.

In the year’s first quarter, membership reached 45.4 million, an increase of approximately 186,000 since the end of 2025. Growth in commercial fee-based plans contributed to the gain, though it was somewhat offset by decreases in Medicare Advantage and employer-sponsored risk-based plans as the company continues to adjust those segments in response to cost pressures.

Meanwhile, Carelon reported revenue of $18 billion, marking an almost 8% increase year over year. This growth was driven by strong performance in CarelonRx as well as continued expansion of Carelon Services, which provides solutions supporting value-based care models

Overview of Elevance Financial Update

Elevance Health has announced an upward revision to its 2026 profit forecast, signaling stronger confidence in its financial trajectory. The updated outlook reflects how Elevance is benefiting from improved visibility into medical costs, a critical factor influencing insurer profitability.

Why Elevance Raised Its Forecast

The decision by Elevance to elevate its 2026 guidance comes as the company gains clearer insights into healthcare utilization trends and cost structures. With more predictable spending patterns, Elevance can better manage pricing strategies and risk, ultimately strengthening margins.

Medical Cost Clarity Driving Elevance Confidence

A key driver behind the revised forecast is enhanced transparency around medical expenses. Elevance has indicated that stabilization in healthcare usage and cost trends allows for more accurate projections. This clarity enables Elevance to optimize operational efficiency and align premiums more effectively with expected costs.